Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Views
administrator
06/15/23
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
-
Category
Show more
Facebook Comments
No comments found